Joel M. Esken

Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases.

S. Dabbs, D. Davies, E. Minthorn, 2016, Bioorganic & medicinal chemistry letters.

Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases.

S. Dabbs, D. Davies, E. Minthorn, 2013, Bioorganic & medicinal chemistry letters.

Toward the development of a structurally novel class of chiral auxiliaries: diastereoselective aldol reactions of a (1R,2S)-ephedrine-based 3,4,5,6-tetrahydro-2H-1,3,4-oxadiazin-2-one.

James R. Burgeson, S. Hitchcock, G. Ferrence, 2002, Organic letters.

Intramolecular chiral relay at stereogenic nitrogen. Synthesis and application of a new chiral auxiliary derived from (1R,2S)-norephedrine and acetone.

S. Hitchcock, G. Ferrence, Jeremy F. Vaughn, 2004, The Journal of organic chemistry.

Conformational studies of N(3)-substituted [1,3,4]-oxadiazinan-2-ones.

S. Hitchcock, G. Ferrence, J. Standard, 2002, The Journal of organic chemistry.

A novel 2 :1 cycloadduct of dimethyl acetylenedicarboxylate with 3,5-diphenyl-4-methoximino-4H-pyrazole 1,2-dioxide

G. Ferrence, A. Kilpatrick, Kalyan C Nagulapalli, 2003 .